Relationship between blood glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics: Subanalysis of a prospective cohort study

To clarify the relationship between ambulatory glucose profile (AGP) indexes and standardized continuous glucose monitoring (CGM) metrics in patients with type 2 diabetes (T2D).

[1]  Y. Bao,et al.  Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes , 2018, Diabetes Care.

[2]  R. Bergenstal,et al.  Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice. , 2019, Diabetes technology & therapeutics.

[3]  D Rodbard,et al.  Ambulatory Glucose Profile: Representation of Verified Self-Monitored Blood Glucose Data , 1987, Diabetes Care.

[4]  Stephanie J. Fonda,et al.  Minding the Gaps in Continuous Glucose Monitoring: A Method to Repair Gaps to Achieve More Accurate Glucometrics , 2013, Journal of diabetes science and technology.

[5]  David C Klonoff,et al.  Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile , 2013, Journal of diabetes science and technology.

[6]  Andrea Facchinetti,et al.  Head-to-head comparison of the accuracy of Abbott FreeStyle Libre and Dexcom G5 mobile. , 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[7]  I. Shimomura,et al.  Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes , 2021, Cardiovascular Diabetology.

[8]  Yoshiya Tanaka,et al.  Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring. , 2018, Diabetes technology & therapeutics.

[9]  I. Shimomura,et al.  Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes , 2019, Diabetes Therapy.

[10]  F. Doyle,et al.  Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range , 2019, Diabetes Care.

[11]  Konrad Pagacz,et al.  Resistance to Data Loss of Glycemic Variability Measurements in Long-Term Continuous Glucose Monitoring. , 2018, Diabetes technology & therapeutics.

[12]  Dongni Zhao,et al.  Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy , 2020, Journal of diabetes investigation.

[13]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  Yoshiya Tanaka,et al.  Enlarged glycemic variability in sulfonylurea-treated well-controlled type 2 diabetics identified using continuous glucose monitoring , 2021, Scientific Reports.

[15]  Y. Loke,et al.  Meta-Analysis: Association Between Hypoglycemia and Serious Adverse Events in Older Patients Treated With Glucose-Lowering Agents , 2021, Frontiers in Endocrinology.

[16]  Yoshiya Tanaka,et al.  Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study , 2020, Diabetology & Metabolic Syndrome.

[17]  R. Beck,et al.  Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials , 2018, Diabetes Care.

[18]  David Rodbard,et al.  Hypo- and hyperglycemia in relation to the mean, standard deviation, coefficient of variation, and nature of the glucose distribution. , 2012, Diabetes technology & therapeutics.

[19]  Pratik Choudhary,et al.  Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. , 2011, Diabetes technology & therapeutics.

[20]  I. Shimomura,et al.  Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes , 2020, BMJ Open Diabetes Research & Care.

[21]  Eyal Dassau,et al.  International Consensus on Use of Continuous Glucose Monitoring , 2017, Diabetes Care.

[22]  Daniel J Cox,et al.  Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. , 2003, Diabetes technology & therapeutics.

[23]  H. Miyoshi,et al.  The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study , 2021, Diabetology & Metabolic Syndrome.

[24]  Roy W Beck,et al.  The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set. , 2019, Diabetes technology & therapeutics.

[25]  Yosuke Okada,et al.  Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus , 2013, Cardiovascular Diabetology.

[26]  D. Owens,et al.  Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes , 2016, Diabetes Care.

[27]  L. Sherar,et al.  Resistance to data loss from the Freestyle Libre: Impact on glucose variability indices and recommendations for data analysis. , 2020, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[28]  Yoshiya Tanaka,et al.  Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring. , 2018, Diabetes technology & therapeutics.